Abstract
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy: more difficult to diagnose, not to control?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have